It looks like the world’s biggest bong, but the photograph from pharmaceutical manufacture IDT Australia is strictly legit.
The Melbourne company has begun manufacturing medicinal cannabis for local producer Cann Group (ASX: CAN).
The first product, medicinal cannabis dried flower, were packed by IDT under GMP certified conditions and will undergo testing ahead of release in the first quarter of the year.
IDT has released videos showing various parts of the manufacturing process including the decarboxylation of medicinal cannabis resin under GMP certified conditions (below).
The main photograph shows large scale distillation of medicinal cannabis resin filtrate.
And bellow is real-time filtration of medicinal cannabis resin extract performed at scale.
It is clearly a fascinating process and one which marks the transition of the medicinal cannabis industry from one of wishful thinking to the real world of manufacturing and marketing.
Cann said in a statement to the stock exchange: “This represents the first commercial-scale resin extraction from Australian grown cultivars.”
Patients can access the Cann product under a special access scheme, with the products distributed to retailers and hospital pharmacies by Symbion Health.
Cann has also exported its first locally manufactured product to Aurora Cannabis Inc of Canada.
Cann CEO Peter Crock said: “IDT has demonstrated a clear capability to manufacture medicinal cannabis products.
“As Cann increases our cultivation and production capacity at the new Mildura facility, it is critical that we have the ability to efficiently convert that material into commercial formulations.”
Picture: IDT Australia
Subscribe to our free @AuManufacturing newsletter here.